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The second rheumatic heart disease (RHD) forum was held on February 18, 2013, at the Sixth World
Congress of Pediatric Cardiology and Cardiac Surgery in Cape Town, South Africa, to focus attention on
key areas in global RHD control, management, and prevention. Building on the foundation of the ﬁrst
RHD forum, over 150 interested participants met to discuss critical issues on the RHD landscape. Unique
to this meeting was a mixture of diverse backgrounds and disciplines, all crucially important to the
conversation around RHD control and prevention. Some clear priorities have emerged for RHD activities in
the next era: the necessity for political intervention and policy change; increasing the health workforce by
incorporating teaching, training, and task-shifting; revitalizing the research agenda by merging basic,
clinical, and translational research; and obtaining universal access to high-quality penicillin. There was also
an urgent request for new resources; for existing resources to be further developed, improved, and shared
across platforms; and for resources to be supported in the nonmedical arena. Finally, the necessity of
involving the patient community in the ongoing discussion was highlighted. The participants of both the
ﬁrst and second RHD forum represent a new, thriving, and growing community of RHD activists who
should usher in a new era of signiﬁcant improvements in RHD control and prevention.vided by the Medtronic
Foundation and Cure Kids.
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The ﬁrst rheumatic heart disease (RHD) forum was held
in April 2012 at theWorld Congress of Cardiology in Dubai,
United Arab Emirates, and assembled for the ﬁrst time manyAL HEART, VOL. 8, NO. 3, 2013
ember 2013: 253-261of those involved in acute rheumatic fever (ARF)/RHD con-
trol, prevention, andmanagement activities across the globe.
This meeting provided 33 participants the opportunity to
meet, share successes, and network mutual challenges. The
World Congress of Pediatric Cardiology andCardiac Surgery
held in Cape Town from February 17 to 22, 2013, was the
natural venue for the second RHD forum as RHD remains the
most common cause of acquired heart disease in children,
adolescents, and young adults [1]. In addition, this confer-
ence had as a central tenet a deliberate focus on issues
affecting the majority of the world’s children with particular
references to diseases of the poor and marginalized people
[2]. For this forum, 4 discussion groups were chaired by
experts in the RHD community: 1) advocacy, policy, public
health, and government engagement; 2) science and
research—priorities and translation; 3) training and capacity-
building; and 4) practical issues in RHD at the country level.
PARTICIPANTS
It was expected that 50 to 60 participants would attend; yet
overwhelming interest resulted in over 150 delegates
attending from 38 countries and all major continents, only
20% of whom had been at the previous RHD forum (Fig. 1,
Table 1). Interestingly, the delegates represented a diverse
group with interests and backgrounds outside of medicine
including law, advocacy, fundraising, and ﬁlmmaking.
OBJECTIVES
The major objective of the forum was to discuss critical
needs around RHD and to share common goals, visions, and
strategies. Another objective was to encourage the253
FIGURE 1. Countries represented at the second RHD forum. RHD, rheumatic heart disease.
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254development of collaborative platforms and programs, and
stress key areas of research, intervention, and emerging
priorities. As the cardiovascular community tackles the
vision of “a 25% reduction in premature deaths fromRHD in
the under 25 years olds by the year 2025” [3], it is critical for
all interested groups working in the RHD space to contribute
to this important conversation and build a new, vibrant,
growing RHD community, allowing for new networks andTABLE 1. Countries represented at the second RHD forum
North America South America Africa
Canada
United States of America
Brazil Angola
Cameroon
Cote D’Ivore
Egypt
Ghana
Kenya
Mozambique
Namibia
Nigeria
Rwanda
South Africa
Sudan
Uganda
Zambia
Zimbabwe
RHD, rheumatic heart disease.friendships to develop (and strengthening of more estab-
lished ones) and to highlight major common areas of need.
The major discussion points follow (Table 2).
Advocacy, policy, public health, and government
engagement
RHD activities have suffered in the recent past by dwindling
public health and government interest, due to decreasingEurope Australasia/Oceania Asia
Austria
Poland
Switzerland
United Kingdom
Australia
Fiji
New Zealand
Republic of Tuvalu
Bangladesh
India
Indonesia
Malaysia
Pakistan
Philippines
Saudi Arabia
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TABLE 2. Advocacy, policy, public health, and government
engagement
National level advocacy  Importance of data
 Mobilizing and engaging
governments
 Community involvement
 RHD champions
 Multimodal media messages
Advocacy to action  Very speciﬁc asks
 Need for equipped medical
workforce
 Health system support
Expansion of RHD control
on a global level
 Mutual support of countries
with variable development
of RHD programs
 Extension of the role of
international organizations
RHD, rheumatic heart disease.
gRECSjprevalence in high-income countries and competing health
interests in lower-income countries [4]. Yet, engagement
with government is critical to effect policy and public health
interventions, whereas community awareness is vital to
encourage activism around RHD. This group focused on
3 key questions in this area:
1. What helps with national level advocacy?
2. How to translate advocacy to action?
3. How to expand RHD control at a global level?National level advocacy There is an urgent need for
surveillance to detail the ARF/RHD burden of disease,
particularly in low-income countries and rural settings. This
is fundamental to comprehensively inform governments
concerned about “endemic” disease conditions and
morbidity and mortality ﬁgures. Strategies for translating
burden of disease data to government engagement and
action were explored. Approaches included: politicizing
the issue (with the elevation of RHD in the national policy
agenda of New Zealand as an example); leveraging the
millennium development goals; and aligning RHD with
issues of child health, maternal morbidity/mortality, and
the noncommunicable disease agenda currently of interest
to many governments.
An essential element to activism and advocacywas to put
a “face” to RHD and escalate active community participation.
Approaches should involve parent, community, and patient
groups such as the patient clubs that have been successful in
Kerala, India [5]. These occasions can provide important
opportunities for education and can draw much-needed
media attention (e.g., the work in Vietnam around
nephrotic syndrome [6]). Educated, adherent patients can be
powerful advocates, and a health minister with a personal
connection to RHD can present a wonderful opportunity.GLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 253-261The suggestion of teaching children at school and having
them educate families at home was also raised.
Leading clinicians with a national proﬁle are needed to act
as clinical champions for RHD and to encourage nonclinical
champions to develop from other arenas. Advocates and
prominent clinicians from within heart foundations have
already been successful in mobilizing governmental support.
Filmstars and sportingheroes canbeverypowerful rolemodels
and lessons could be learned from other disease intervention
strategies such as the polio eradication campaign in India.
The importance of multimodal media outputs was
stressed. Brochures can help people living with ARF/RHD
understand the condition; however, literacy can be a sig-
niﬁcant challenge. Increasing public messages can build
media interest, creating a global chorus for action. Docu-
mentaries, short ﬁlms, and interviews can be powerful
advocacy tools and can mobilize people otherwise
disconnected from ARF/RHD, particularly from high-
resource settings. Finally, using social media platforms
such as Facebook and Twitter was proposed, acknowl-
edging that these could be difﬁcult to access in very low-
resource settings (Table 3).
Advocacy into action—knowledge translation,
translational research The greatest challenge in RHD is
implementing the knowledge and evidence that already
exists. ARF/RHD can be controlled with sufﬁcient aware-
ness, advocacy, and mobilization of political will.
Some speciﬁc “asks” may be the ﬁrst step in this regard.
ARF/RHD is a disease of poverty and poor social infrastruc-
ture; advocacy efforts should always emphasize primordial
prevention. The next major “ask” relates to the health work-
force. Translating our current evidence into practicable pro-
grams requires a trainedmedicalworkforce able to implement
RHD programs. Countries reported variable compliance with
clinical guidelines and inadequate education regarding the
importance of secondary prevention. Evenwithin themedical
profession, inadequate understanding of the diseasemay exist
and result in suboptimal promotionof secondaryprophylaxis.
In addition, the informal medical sector may be difﬁcult to
access or regulate in many areas.
RHD control at a global level One of the main objec-
tives of the ﬁrst RHD forum was to support those working in
countries with less-developed RHD programs. This can take
various guises: sharing of protocols and scientiﬁc data visits;
joint projects; introductions to funding opportunities and
establishing local and regional priorities; advocating to
government; and forming groups of disease champions.
The World Heart Federation (WHF) position statement
is expected to behelpful for countries to adapt to local settings
or recommendations, although more technical support may
be needed to help with local-level implementation (Table 3).
International organizations and industry have an
important role exerting a top-down inﬂuence on policy
makers at international and government levels. The impor-
tance of theWorld Health Assembly (held in May 2013) was255
TABLE 3. Selected resources for RHD community (cited in this document)
Curricula/resources  WHO technical report: http://whqlibdoc.who.int/trs/WHO_TRS_923.pdf
 WHF curriculum: http://www.world-heart-federation.org
 Position statement of the WHF on the prevention and control of rheumatic heart disease: http://
www.nature.com/nrcardio/journal/v10/n5/full/nrcardio.2013.34.html
 UNICEF’s Facts for Life: http://www.unicef.org/publications/index_53254.html
 WHF criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based
guideline: http://www.nature.com/nrcardio/journal/v9/n5/full/nrcardio.2012.7.html
 WHO pocket book: http://www.who.int/maternal_child_adolescent/documents/9241546700/en/
Websites  www.worldheart.org/rhd
B Includes resources, training manuals, guidelines, and articles
 www.RHDaustralia
B Includes resources, training manuals, guidelines, and monthly newsletter
 http://www.ncdalliance.org/
 http://www.clanchildhealth.org/
 http://www.ncdchild.org/
 http://www.curekids.org.nz/
Training  http://www.pih.org/library/the-pih-guide-to-chronic-care-integration-for-endemic-non-
communicable-dise
 Global research priorities in rheumatic fever and rheumatic heart disease: http://www.ncbi.nlm.
nih.gov/pmc/articles/PMC3104531/
 Simpliﬁed Echocardiographic Strategy for Heart Failure Diagnosis and Management Within an
Integrated Non-Communicable Disease Clinic at District Hospital Level for Sub-Saharan Africa:
http://www.ghdonline.org/ncd/discussion/simpliﬁed-echocardiographic-strategy-for-heart-fa/?
id¼308828&format¼html&type¼digest
 African pediatric fellowship program: http://www.scah.uct.ac.za/apfp/APFP
Basic sciences research  Vaccine development: http://ip.bio-med.ch/cms/cms
Videos, interviews,
YouTube links
 http://www.youtube.com/watch?v¼tWMGNG61SRA
 http://www.youtube.com/watch?v¼MoWJiupOBo4
 http://www.youtube.com/watch?v¼eUFpNK2ljgw
 http://www.youtube.com/watch?v¼dB7eXTh6zdg
 http://www.youtube.com/watch?v¼0J6Tf3cv8sg
 http://www.rheumaticheartclub.org/
Apps for iPhone, iPad, or
Android
 www.rhdaustralia.au
Guidelines  Australia and New Zealand: http://www.rhdaustralia.org.au/sites/default/ﬁles/guideline_0.pdf
 India: http://www.ncbi.nlm.nih.gov/pubmed/1869527
UNICEF, United Nations Children’s Fund; WHF, World Health Federation; WHO, World Health Organization.
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256highlighted as an opportunity to inform ministers of health
about RHD. The United Nations Children’s Fund has pro-
duced a document titled Facts for Life, with a series of
chapters on raising healthy children, that provides practical
tips for policy makers and health professionals. Other useful
tools exist: WHF’s dedicated RHD website, RHDNet, pro-
vides resources, although all these resources should be more
dynamic and high proﬁle in order to generate as much in-
terest as possible (Table 3).
One suggestion was for an A4 factsheet of hard data to
distribute that would provide consistent, powerful mes-
sages required for global advocacy. Finally, all participants
supported ongoing advocacy efforts directed at the phar-
maceutical and biomedical industry to improve the globalbenzathine penicillin G supply and to consider low-cost
tertiary interventions. Industry partners also have skills
and experience relevant to broader disease control efforts.
Science and research—priorities and translation
The following areas were identiﬁed as research priorities
(Table 4).
Interdisciplinary interaction to direct research
priorities More collaboration among members at all
levels (including scientists, healthcare workers, clinicians,
echo technologists, nurses, health educators, etc.) within
the RHD community will foster the exchange of ideas for
topics for research from basic research to knowledgeGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 253-261
TABLE 4. Science and research—priorities and translation
Coordination of
research
 Interdisciplinary interaction to direct
research priorities
 Registries as a research tool, espe-
cially in resource-poor countries
 Global collaboration
Applied science  Screening interventions
 Treatment interventions
 Vaccine development
Basic sciences
research
 GAS pharyngitis
 Strep registries
 M protein gene typing
 Genetic studies
GAS, group A streptococcus.
TABLE 5. Training and capacity-building priorities
Training  Sensitizing healthcare workers
 Training at all levels with a wide range of
outputs
 Targets including heathcare workers,
communities, schools teachers, patients,
and families.
 Integration of ARF and RHD training in
existing health worker education programs
 Collaboration and networking
 Exchange programs
Capacity-
building
 National algorithms and referral systems
 Sustainable models for low-cost
technology
 Sustainable models for cardiology and
surgical services
ARF, acute rheumatic fever; RHD, rheumatic heart disease.
gRECSjtranslation. In particular, more contact between basic and
clinical sciences will steer efforts in providing answers to
questions arising from within the clinical environment.
A clear need exists for registries as a research tool,
especially in resource-poor countries, which will also
facilitate the development of country-speciﬁc priorities
for prevention. Furthermore, if similar protocols are
used, combining data across registries will allow for the
evaluation of the natural course of disease at a global
level. The research can also be extended to trials
involving multicenter institutions on the notiﬁcation of
ARF. In addition, there is a need to have research
targeting the strengthening of health systems to ensure
adequate management of cases. There was a call for
assistance in setting up RHD programs where they
currently do not exist.
Global collaboration Participants strongly suggested
that investigators of programs emanating frommore afﬂuent
settings consider including units from less-developed
countries when planning research and applying for grants,
especially in screening for RHD. Sharing training
opportunities, for example, in echocardiography, will serve
to strengthen the global network in RHD research.
Development of effective screening and treatment
interventions There is a need to research and develop
screening interventions that will be effective in diagnosing
RHD in its early stages, especially in those resource-poor
settings where surgery is not an option. Screening-related
research should focus on: 1) identifying indicators of higher
risk in children characterized as “borderline RHD” by the
WHF criteria to answer the question of when to start
prophylaxis; 2) identifying more cost-effective interventions
(e.g., hand-held echo or nurse-led screening); 3) identifying
community-based approaches to improve the accuracy of
epidemiologic ﬁndings; and 4) performing cost-effectiveness
analyses.
Given the concerns regarding adherence to secondary
prophylaxis, treatment-related research should focus onGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 253-261effective and innovative means of delivery while encour-
aging adherence. There is also a need for an evidence base
for current treatment strategies to be developed. This
should include further research on penicillin as a pro-
phylactic drug, drugs being used for patients with heart
failure, and alternatives to the more expensive drugs
currently used. There was consensus that concerted efforts
should be directed at developing a vaccine for group A
streptococcus (GAS).
Basic sciences research More studies are needed on
ways of accurately identifying GAS in the absence of labo-
ratory facilities, in other words, developing clinical predic-
tion rules, given that many cases occur in rural areas devoid
of clinic facilities. The development of registries to record
streptococcal infection, especially in resource-poor settings,
will serve as a useful tool to document the epidemiology
of GAS-related infections. Studies on M protein gene
typing are also needed to inform the development of
potential M proteinebased vaccines. Genetic studies may
serve to identify indicators of RHD disease before the
onset of symptoms and the individuals most likely to
beneﬁt from a potential vaccine, thus reducing the overall
cost of vaccination.Training and capacity building
A serious concern in combating RHD is the lack of sufﬁ-
cient training and health worker capacity in high preva-
lence areas. This was expressed by all participants in each
group. However, sensitizing all levels of healthcare workers
to RHD was the important initial step to raise awareness,
then to generate interest in training, and then ﬁnally to
offer appropriate training (Table 5).
Training requirements are complex, multilevel, and
should include deﬁnitions for each role (e.g., teachers,
nurses, community workers, general practitioners,257
TABLE 6. Practical issues at a country level
Penicillin  Benzathine penicillin remains
the most effective primary and
secondary preventive agent for
ARF/RHD.
 Serious concerns remain
regarding the availability, quality,
delivery, and safety of penicillin
from many areas of the world.
Treatment of sore
throat
 Sore throats are still
under-recognized and
undertreated.
 Need for local clinical prediction
rules.
 Streptococcal sore throat
programs needed.
Warfarin  Point-of care INR is a critical
need in order to monitor
warfarin use.
National policy of
notiﬁable diseases
 Governments should be
encouraged to make ARF/RHD
notiﬁable and to support local
registries.
Surgical capacity  Surgical capacity remains a
concern for those caring for
patients with advanced disease.
INR, international normalized ratio; other abbreviations as in
Tables 1 and 5.
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258specialists) regarding expectations and desired outcomes.
In South Africa, a pilot workshop trained school nurses to
educate other nurses, teachers, and pupils using a locally
produced DVD. It was strongly recommended that a na-
tional committee be nominated to lead training and inte-
grate ARF/RHD training into existing health workers’
education programs. Practically, anaphylaxis training must
be a pre-requisite for all those involved in penicillin de-
livery and is critical to building conﬁdence in the program
among those instituting the delivery.
The need for human resources was well illustrated by the
example of Rwanda with a desperate shortage of skilled
workforce. Currently, there are only 2 pediatric cardiologists
for a population of 10 million; also, there is a dire shortage of
pediatricians. Existing options to address these realities
include task-shifting and integrated management models.
General practitioners are trained in RHD management and
have become the ﬁrst line of contact. A 1-year diploma in
cardiology is also being offered in Rwanda, and non-
communicable disease nurses are currently undergoing
echocardiography training. Other centers have trained radi-
ographers or radiology technicians in echocardiography.
Another thought was to offer theWHF curriculum in a 1-year
diploma that could also be offered as distance learning.
Currently, RHD Australia has training modules online. There
is also a U.S. guideline for emergency echo.
Colleagues from Egypt highlighted that they were not
short of training nor doctors, but they urgently needed in-
dividuals with experience in data management, statistics, and
ethics. Research infrastructure was also generally insufﬁcient,
resulting in decreased research capacity. All participants were
concerned that managing available resources was a priority,
but it was challenging without administrative staff and
ﬁnancial support.
One proposition was the expansion of exchange pro-
grams to up-skill clinicians and make available local and
overseas opportunities. These need not be the typical
north-south collaborative model; they could be south-
south coordinated training, intracontinental, or regional
(Table 3). It was clear that all the specialties needed to be
trained and informed (pediatrics, adult medicine, cardiol-
ogy, infectious disease) using strategies appropriate for
different cadres of health workers. Surgeons in the groups
felt that many of their colleagues found ischemic heart
disease surgery more appealing than RHD work, but
others were keen to tackle the challenges of valve surgery.
Surgeons generally found the interface with the rest of the
health system challenging.
Finally, some practical concerns were debated. It was
felt that referral systems needed to be developed with na-
tional or regional algorithms promulgated. Sustainable
models for international normalized ratio (INR) monitoring
and the high costs of cardiovascular technology remain
concerning in low-income countries. For surgical services
to succeed, local interest must be generated to sustain
surgical programs and medico-surgical centers need to be
accountable to local and regional needs.Practical issues in RHD control at a country level
Many of the points raised in the ﬁrst 3 groups were echoed
in this group discussion, which grappled with practical
issues on a country level (Table 6).Penicillin
 Availability: The majority of the participants expressed
serious concerns regarding the availability, quality, and
safety of penicillin. In view of the evidence of efﬁcacy of
benzathine penicillin, the realities of intermittent supplies
and the inadequate response of pharmaceutical companies
and governments to ensure regular, high-quality penicillin
is alarming. All countries report an even poorer supply of
oral penicillin, used when benzathine was unavailable or
not permitted, as in certain areas of India. Indian delegates
remarked on the suboptimal compliance with oral peni-
cillin and an observed increased recurrence rate once ben-
zathine penicillin was discontinued in their states (because
of concerns around anaphylaxis). All countries represented
had different dosage intervals and thus were variably
affected by poor supply.
Penicillin thus remains a critical issue for any
comprehensive RHD program and a major focus area to be
tackled over the next 5 years.GLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 253-261
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 Anaphylaxis: Deaths due to anaphylaxis, although rare,
have been followed by cessation of secondary prevention
programs using benzathine penicillin G in some settings.
There were a variety of approaches to preventing
anaphylactic deaths. One method was increasing the
availability of and training in the use of anaphylaxis kits,
whereas another was introducing regular skin testing. In
1 Indian center, RHD patients have skin tests prior to
each injection. In Nepal, these were performed with the
ﬁrst injection, each batch change, and each brand
change. New brand and constant batch changes were
challenges both in India and Pakistan and have resulted
in either skin tests or test doses with each injection. Two
other strategies were presented: 1) In Brazil, a family
history is taken prior to delivery of benzathine penicillin;
adrenaline is always pre-loaded; and the patient is
observed for 40 min after administration. In New Zea-
land, the ﬁrst injections are done in a hospital with the
rest delivered entirely by nurses in community settings.
In South Africa, primary healthcare nurses are routinely
involved in other benzathine penicillin delivery pro-
grams (such as treatment of syphilis). These units are
largely not equipped with anaphylaxis kits, although
nurses are taught anaphylaxis management.
Generally, it was felt that further research was needed
into the causes and mechanism of anaphylaxis and pre-
vention of anaphylaxis events. Many feel that anaphylactic
events are often due to reactions to reagents or impurities
rather than to the penicillin itself, yet anaphylaxis has the
potential to entirely derail a functioning secondary pro-
phylaxis program. This should be a keen priority research
area.
 Delivery: All participants agreed that the evidence indi-
cated that 2-weekly penicillin doses were highly effec-
tive. However, such regular administration was
problematic in many areas of the world, and thus the
standard regimen in most groups was 4-weekly doses.
Compliance and adherence remain a major concern and
different strategies were outlined. One approach
included the situation in Perth, Australia, where nurses
visit schools and homes to administer penicillin. The
consensus was in favor of employing several strategies
depending on the environment and target population.
New models were reviewed with comparisons of suc-
cesses and failures. Studies determining the barriers to
adherence are critically needed as is structured evalua-
tion of successful programs. For those on oral prophy-
laxis, another suggestion was using the directly observed
therapy strategy used in tuberculosis management.
The role of the healthcare worker involved in benzathine
penicillin delivery was also strongly debated. Skilled health
workers are scarce in all regions with high RHD prevalence
and increased adherencewill place extra demands on already
stressed health systems. Integration with coexisting benza-
thine programs, such as for syphilis treatment, may result inGLOBAL HEART, VOL. 8, NO. 3, 2013
September 2013: 253-261shared costs and possibly improved adherence. Each region
should look at their adherence and recurrence rates and the
current staff providing penicillin delivery in order to adopt
the most successful model. The value of experienced, highly
skilled nurses cannot be overemphasized. Reducing the pain
of the benzathine injection is an important aspect of
increasing adherence; skills in this area should be taught to
all community and primary healthcare workers. Adjuncts
such as lignocaine, the use of separate needles, normal saline,
and slow injections should be practiced.
Simple, cheap, and innovative models are required to
support existing health systems to improve compliance.
These include delegating prescription authority from doc-
tors to nurses for benzathine penicillin G and text message
reminders for benzathine penicillin G doses. A suggestion
was to provide small incentives for families to bring chil-
dren for prophylaxis (e.g., offering a sibling an examina-
tion). The use of Internet and electronic records can
improve standardization, making the program delivery
safer and easier to monitor.
Treatment of sore throat The treatment of sore throat is
pivotal to reducing the burden of ARF and eventually RHD in
our communities. However, all participants agreed that sore
throats were untreated and under-recognized as the primer
to RHD. The Nepalese slogan of “a sore throat can break
your heart” accompanied by a stern picture of Dr. Prakash
Regmi, from the Nepalese Heart Foundation, has been
widely distributed throughout Nepal, with good effect. A
variety of similar strategies was deliberated, including the
use of community health workers or health posts to
diagnose and treat sore throats in Rwanda, Zambia, or
Nigeria. Although it was agreed that every sore throat
should be treated, the consensus was that at least 40%
were being missed.
Most regions were treating sore throats with benza-
thine penicillin, which once again raised many previously
mentioned concerns. The evidence for clinical prediction
rules was discussed, and the need for further research in
this area was mentioned. In addition, research on rapid
streptococcal test kits in developing countries is needed to
delineate its role, if any, to improve diagnostic yield and
treat strep throat.
Different strep throat programs were reviewed. Brazil
has a good national strep throat program with reasonable
awareness of streptococcal sore throat. This is a result of a
local university initiative with evidence-based guidelines
tailored to the region. The importance of awareness among
children and in schools was stressed and the importance
and previous success stories (Cuba) of mass education
cited [7]. Work continues in the Philippines, India, and
Pakistan focusing on awareness and education in smaller
group sessions.
Warfarin Another strongly expressed lack was for
warfarin and monitoring of warfarin use for those with
atrial ﬁbrillation and/or mechanical prosthesis. Although259
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ters, this was not often the case in regional hospitals or
health posts. Access to INR monitoring was far less likely to
be available in remote or rural areas. Many participants
expressed a dire need for point-of-care INR testing, as they
all perceived this as a real problem. As a result, many
patients were commenced on aspirin only.
National policy of notiﬁable diseases ARF is only
notiﬁable in New Zealand, parts of Australia, and South
Africa. However, this was not without problems, despite the
obvious advantages [8]. The importance of burden of disease
estimates, recurrence monitoring, and case ﬁnding was
explored and reinforced. Many participants expressed their
frustration at the lack of data and the sense of “not
knowing what is going on.” It was clear, however, that
great strides have been made in terms of hospital registries.
In addition, registries compiled by organizations such as
the Nepalese Heart Foundation have been incorporated
into national control and prevention programs with input
from governments and departments of health. In Rwanda,
electronic integration of all chronic diseases has resulted
in a national chronic disease program (Table 3). The
importance of integrated programs in resource-poor
settings was emphasized while stressing the speciﬁc uses of
a local RHD registry.
Surgical capacity Finally, the focus turned to surgical
capacity in countries with overwhelming burden of dis-
ease. The group represented different levels of capacity
from mixed public and private surgical services with no
real limits (Australia, New Zealand, and Unites States) to
centers with no surgery (Nigeria and Zambia) and those
with only visiting surgical teams (Rwanda). The difﬁculties
of balancing adult versus pediatric surgical programs,
building new surgical capacity within affected countries,
and needing to have surgery performed outside of the
countries (from Africa to India or Israel) were examined in
detail. Many participants bemoaned the fact that the major
crisis lay in healthcare manpower, whereas others dis-
cussed the realities of the brain drain and the attraction of
other climes on recently skilled physicians or surgeons. Of
those involved in visiting surgical teams, the frustration of
being able to do only a limited amount of surgery was
expressed. On the other hand, a major concern was that in
these situations, valve replacements were performed in
preference to valve repairs. The need exists for better
business models for effective low-cost technology without
affecting the patient’s care. In Brazil, prosthetic valves are
cheaper than mitral rings, which has increased the
amount of valve replacements rather than the preferred
valve repair. The inherent difﬁculties in patient selection,
especially for surgery in other countries, were also
discussed.
In general, the reality was long waiting lists for valve
surgery with patients dying on these lists. Some emerging
country centers such as Nepal, Brazil, and South Africado have surgical capacity (some even free of charge or
heavily subsidized), but they also have extensive
waiting lists that include patients from other countries.
Advocacy efforts and increased awareness in India, the
Philippines, and Nepal have resulted in increased case
ascertainment and, subsequently, increasing demand for
surgery.
CONCLUSIONS
The second RHD forum was a remarkable event. Building
on the foundation of the ﬁrst RHD forum, over 150
interested participants were able to meet and discuss crit-
ical issues on the RHD landscape. Unique to this meeting
was a mixture of diverse backgrounds and disciplines,
all crucially important to the conversation of RHD control
and prevention. It is clear that new leadership is emerging
in the RHD space, as well as new focus points beyond
medical management to political and policy decisions
and interventions. The networking that occurred should
encourage new research collaborations and sharing of
resources and expertise. Some priorities have emerged: the
necessity for political intervention and policy change; the
need to increase the health force by incorporating teaching,
training, and task-shifting; the need to revitalize the
research agenda by merging basic, clinical, and trans-
lational research; and, ﬁnally, the desperate need for uni-
versal access to high-quality penicillin. There were also
requests for new resources; for those that already exist to
be further developed, improved, and shared across plat-
forms; and for resources to be supported in nonmedical
arenas. Finally, the need to involve the patient community
in the ongoing discussion was highlighted.
The RHD forum has thus far convened at cardiology
congresses that focused attention on medical participants.
In the future, consideration should be given to include
patient and parent groups, as well as the nonclinical dis-
ciplines needed for comprehensive disease activism. It is
time to effect concrete change in RHD activities across the
world, and we hope that the RHD forum will be part of the
solution, rather than a reﬂection of current problems.
Several important initiatives and champions, we envisage,
will be born out of these forums and continue to invigorate
RHD activities over the next years. The participants of both
the ﬁrst and second RHD forums represent a new, thriving,
growing community of RHD activists who should usher in
a new era of signiﬁcant improvements in RHD control and
prevention expanding beyond the borders of high-income
nations.
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